-
2000
Company Description
Symphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.
Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.
-
Manufacturer:
Science and Engineering -
Formed:
2000 -
Founders:
Kirsten Drejer -
Company Website:
-
Company E-mail:
-
Company Address:
Elektrovej Building 375LyngbyDenmark -
CEO:
- Kirsten Drejer
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits